VIMLAYAH

Serial Number 98912354
681

Registration Progress

Application Filed
Dec 19, 2024
Under Examination
Approved for Publication
Published for Opposition
Jul 22, 2025
Registered

Attorney Assistance

Non-Final Action Mailed
Due: Sep 09, 2025 62 days

Basic Information

Serial Number
98912354
Filing Date
December 19, 2024
Published for Opposition
July 22, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
681
Status Date
Jul 1, 2025
Application
Pending
Classes
005 042

Rights Holder

Denali Therapeutics Inc.

03
Address
161 Oyster Point Boulevard
South San Francisco, CA 94080

Ownership History

Denali Therapeutics Inc.

Original Applicant
03
South San Francisco, CA

Legal Representation

Attorney
Chelseaa Larsen

USPTO Deadlines

Next Deadline
62 days remaining
Non-Final Action Mailed
Due Date
September 09, 2025
Extension Available
Until December 09, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

13 events
Date Code Type Description
Jun 17, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2025 GNRT F NON-FINAL ACTION E-MAILED
Jun 9, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 9, 2025 CNRT R NON-FINAL ACTION WRITTEN
Jun 5, 2025 DOCK D ASSIGNED TO EXAMINER
Apr 28, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 5, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 5, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 5, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 19, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for diagnosing and treating neurodegenerative diseases; pharmaceutical preparations for the prevention and treatment of lysosomal storage diseases
Class 042
Scientific research, pharmaceutical research, and medical research; technical consultation and product development for investigators and researchers and neurologists in the field of development of pharmaceuticals

Classification

International Classes
005 042